Nijhuis M - Search Results

1

Autopsy Study Defines Composition and Dynamics of the HIV-1 Reservoir after Allogeneic Hematopoietic Stem Cell Transplantation with CCR5Δ32/Δ32 Donor Cells.

Huyveneers LEP, Bruns A, Stam A, Ellerbroek P, de Jong D, Nagy NA, Gumbs SBH, Tesselaar K, Bosman K, Salgado M, Hütter G, Brosens LAA, Kwon M, Diez Martin J, van der Meer JTM, de Kort TM, Sáez-Cirión A, Schulze Zur Wiesch J, Boelens JJ, Martinez-Picado J, Kuball JHE, Wensing AMJ, Nijhuis M; IciStem Consortium. Huyveneers LEP, et al. Among authors: nijhuis m. Viruses. 2022 Sep 17;14(9):2069. doi: 10.3390/v14092069. Viruses. 2022. PMID: 36146874 Free PMC article.

2

Efficacy of adding indinavir to previous reverse transcriptase nucleoside analogues in relation to genotypic and phenotypic resistance development in advanced HIV-1-infected patients.

Ruiz L, Nijhuis M, Boucher C, Puig T, Bonjoch A, Martínez-Picado J, Marfil S, de Jong D, Burger D, Arnó A, Balagué M, Clotet B. Ruiz L, et al. Among authors: nijhuis m. J Acquir Immune Defic Syndr Hum Retrovirol. 1998 Sep 1;19(1):19-28. doi: 10.1097/00042560-199809010-00003. J Acquir Immune Defic Syndr Hum Retrovirol. 1998. PMID: 9732064 Clinical Trial.

3

A novel real-time PCR assay to determine relative replication capacity for HIV-1 protease variants and/or reverse transcriptase variants.

van Maarseveen NM, Huigen MC, de Jong D, Smits AM, Boucher CA, Nijhuis M. van Maarseveen NM, et al. Among authors: nijhuis m. J Virol Methods. 2006 May;133(2):185-94. doi: 10.1016/j.jviromet.2005.11.008. Epub 2005 Dec 20. J Virol Methods. 2006. PMID: 16368153

4

An increase in viral replicative capacity drives the evolution of protease inhibitor-resistant human immunodeficiency virus type 1 in the absence of drugs.

van Maarseveen NM, de Jong D, Boucher CA, Nijhuis M. van Maarseveen NM, et al. Among authors: nijhuis m. J Acquir Immune Defic Syndr. 2006 Jun;42(2):162-8. doi: 10.1097/01.qai.0000219787.65915.56. J Acquir Immune Defic Syndr. 2006. PMID: 16645546

5

Persistence of HIV-1 variants with multiple protease inhibitor (PI)-resistance mutations in the absence of PI therapy can be explained by compensatory fixation.

van Maarseveen NM, Wensing AM, de Jong D, Taconis M, Borleffs JC, Boucher CA, Nijhuis M. van Maarseveen NM, et al. Among authors: nijhuis m. J Infect Dis. 2007 Feb 1;195(3):399-409. doi: 10.1086/510533. Epub 2006 Dec 29. J Infect Dis. 2007. PMID: 17205479

6

Failure of treatment with first-line lopinavir boosted with ritonavir can be explained by novel resistance pathways with protease mutation 76V.

Nijhuis M, Wensing AM, Bierman WF, de Jong D, Kagan R, Fun A, Jaspers CA, Schurink KA, van Agtmael MA, Boucher CA. Nijhuis M, et al. J Infect Dis. 2009 Sep 1;200(5):698-709. doi: 10.1086/605329. J Infect Dis. 2009. PMID: 19627247

7

Fifteen years of HIV Protease Inhibitors: raising the barrier to resistance.

Wensing AM, van Maarseveen NM, Nijhuis M. Wensing AM, et al. Among authors: nijhuis m. Antiviral Res. 2010 Jan;85(1):59-74. doi: 10.1016/j.antiviral.2009.10.003. Epub 2009 Oct 22. Antiviral Res. 2010. PMID: 19853627 Review.

8

Therapy failure following selection of enfuvirtide-resistant HIV-1 in cerebrospinal fluid.

van Lelyveld SF, Nijhuis M, Baatz F, Wilting I, van den Bergh WM, Kurowski M, de Jong D, Hoepelman AI, Wensing AM. van Lelyveld SF, et al. Among authors: nijhuis m. Clin Infect Dis. 2010 Feb 1;50(3):387-90. doi: 10.1086/649874. Clin Infect Dis. 2010. PMID: 20047481

9

Mutation Q95K enhances N155H-mediated integrase inhibitor resistance and improves viral replication capacity.

Fun A, Van Baelen K, van Lelyveld SF, Schipper PJ, Stuyver LJ, Wensing AM, Nijhuis M. Fun A, et al. Among authors: nijhuis m. J Antimicrob Chemother. 2010 Nov;65(11):2300-4. doi: 10.1093/jac/dkq319. Epub 2010 Aug 24. J Antimicrob Chemother. 2010. PMID: 20736234

10

Maraviroc is able to inhibit dual-R5 viruses in a dual/mixed HIV-1-infected patient.

Symons J, van Lelyveld SF, Hoepelman AI, van Ham PM, de Jong D, Wensing AM, Nijhuis M. Symons J, et al. Among authors: nijhuis m. J Antimicrob Chemother. 2011 Apr;66(4):890-5. doi: 10.1093/jac/dkq535. Epub 2011 Jan 28. J Antimicrob Chemother. 2011. PMID: 21393136

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

143 results

Search Page